共 19 条
[1]
Packer M., Bristow M.R., Cohn J.N., Et al., The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, pp. 1349-1355, (1996)
[2]
The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial, Lancet, 353, pp. 9-13, (1999)
[3]
Cockroft J.R., Chowenczyk P.H.J., Brett S.E., Et al., Nebivolol vasodilates human forearm vasculature: Evidence for L-arginin/NO dependent mechanism, J Pharmacol Exp Ther, 274, pp. 1067-1071, (1995)
[4]
Brehm B.R., Wolf S.C., Bertsch D., Et al., Effects of nebivolol on proliferation and apoptosis on human coronary artery smooth muscle and endothelial cells, Cardiovasc Res, 49, pp. 430-439, (2001)
[5]
Brehm B.R., Wolf S.C., Gorner S., Et al., Effect of nebivolol on left ventricular function in patients with chronic heart failure: A pilot study, Eur J Heart Fail, 4, pp. 757-763, (2002)
[6]
Wolf S.C., Buck-Muller N., Gorner S., Et al., Influence of the beta-blocker nebivolol on the left ventricular function in patients with chronic heart failure, Med Klin, 98, pp. 1-6, (2003)
[7]
Brune S., Schmidt T., Tebbe U., Et al., Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure, Angiology, 4, pp. 696-701, (1990)
[8]
Nodari S., Metra M., Dei Cas L., Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension: A prospective, randomized, comparison of the long-term effects of atenolol vs nebivolol, Eur J Heart Fail, 5, pp. 621-627, (2003)
[9]
Schiller N.B., Shah P.M., Crawford M., Et al., Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, J Am Soc Echocardiogr, 2, 5, pp. 358-367, (1989)
[10]
Quinones M.A., Otto C.M., Stoddard M., Et al., Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography, J Am Soc Echocardiogr, 15, pp. 167-184, (2002)